sun
suppress
effect
dengu
viru
envelop
protein
domain
iii
megakaryopoiesi
abstract
dengu
viru
denv
infect
caus
sever
lifethreaten
event
specif
treatment
denv
infect
current
approv
although
thrombocytopenia
frequent
observ
dengu
patient
pathogenesi
still
fulli
understood
previou
studi
suggest
denvinduc
thrombocytopenia
occur
viralreplicationmedi
megakaryopoiesi
inhibit
bone
marrow
howev
exact
mechan
megakaryopoiesi
suppress
remain
elus
studi
reductionist
approach
appli
mice
inocul
recombin
denvenvelop
protein
domain
iii
denveiii
instead
full
viral
particl
result
demonstr
denveiiisuppress
megakaryopoiesi
similar
observ
denv
infect
furthermor
agreement
vivo
analys
denveiii
suffici
suppress
megakaryopoiesi
progenitor
cell
murin
bone
marrow
human
cord
blood
vitro
addit
analys
suggest
autophagi
impair
apoptosi
involv
denveiiimedi
suppress
megakaryopoiesi
data
suggest
even
without
viral
replic
bind
denveiii
cell
surfac
suffici
suppress
megakaryopoiesi
dengu
viru
denv
transmit
mosquito
infect
caus
dengu
sever
dengu
also
known
dengu
hemorrhag
fever
nearli
million
report
case
annual
although
thrombocytopenia
frequent
observ
manifest
denv
infect
significantli
associ
sever
dengu
patient
one
warn
sign
world
health
organ
guidelin
mechan
remain
elus
increas
destruct
platelet
peripher
blood
decreas
product
platelet
bone
marrow
major
caus
thrombocytopenia
previou
report
demonstr
monoclon
antinonstructur
protein
denv
could
crossreact
human
fibrinogen
thrombocyt
endotheli
cell
antidenv
antibodi
could
recogn
protein
platelet
inhibit
platelet
aggreg
thu
caus
platelet
lysi
presenc
complement
denv
protein
elicit
plateletbound
immunoglobulin
ig
acceler
clearanc
phagocyt
complementmedi
lysi
activ
platelet
lead
develop
thrombocytopenia
studi
reveal
platelet
infect
denv
produc
dengu
virallik
particl
patient
dengu
studi
demonstr
thrombocytopenia
induc
antidenv
antibodi
elicitedplatelet
destruct
directli
denv
infect
platelet
inducedplatelet
dysfunct
peripher
blood
megakaryocyt
mk
platelet
precursor
cell
present
bone
marrow
denv
observ
inhibit
megakaryopoiesi
infect
induc
apoptosi
earli
megakaryocyt
progenitor
vitro
consist
thrombocytopenia
result
suppress
bone
marrow
platelet
synthesi
observ
human
patient
denvinfect
human
mice
respect
furthermor
direct
infect
bone
marrow
mk
denv
demonstr
nonhuman
primat
model
dengu
patient
product
viral
particl
mkerythrocyt
progenitor
cell
also
demonstr
evid
collect
suggest
denvinfectionelicit
thrombocytopenia
partli
induc
megakaryopoiesi
inhibit
bone
marrow
mechan
remain
elus
denv
virion
spheric
envelop
viru
diamet
approxim
nm
virion
contain
structur
protein
capsid
c
membran
envelop
e
rna
genom
e
protein
major
protein
virion
surfac
e
glycoprotein
divid
function
domain
central
domain
domain
ei
dimer
fusion
domain
domain
ii
eii
receptorbind
domain
domain
iii
eiii
absenc
direct
viral
infect
human
hepat
c
viru
envelop
glycoprotein
induc
inflammatori
respons
apoptosi
human
umbil
vein
endotheli
cell
howev
whether
bind
denveiii
cellsurfac
receptor
similarli
induc
cellular
signal
toxic
remain
unclear
differenti
haematopoiet
progenitor
cell
includ
mk
extrem
sensit
perturb
cellular
signal
accordingli
studi
hypothes
denveiii
could
suppress
megakaryopoiesi
test
hypothesi
vivo
effect
denveiii
megakaryopoiesi
suppress
evalu
mous
model
colonyform
unit
cfu
assay
mk
cfumk
assay
megakaryocyt
differenti
perform
vitro
use
human
cord
bloodderiv
c
cell
mous
bone
marrow
cell
cord
blood
cell
collect
fullterm
pregnanc
case
depart
obstetr
gynecolog
mennonit
christian
hospit
hualien
taiwan
written
inform
consent
provid
particip
studi
follow
protocol
approv
research
ethic
committe
hualien
tzu
chi
hospit
buddhist
tzu
chi
medic
foundat
approv
id
experiment
protocol
relat
anim
studi
conduct
accord
nation
guidelin
anim
protect
act
taiwan
approv
institut
anim
care
use
committe
tzu
chi
univers
approv
id
strain
amplifi
mosquito
cell
line
atcc
viru
titer
determin
plaqu
assay
use
cell
atcc
describ
previous
construct
protein
purif
plasmid
contain
denveiii
amino
acid
kindli
provid
prof
yile
lin
institut
biomed
scienc
academia
sinica
taiwan
achiev
suffici
quantiti
easi
purif
induct
protein
dna
fragment
encod
denveiii
subclon
express
vector
novagen
madison
wi
ecori
cut
bamhi
cut
site
fill
enabl
infram
construct
translat
recombin
denveiii
protein
fuse
plasmid
transform
escherichia
coli
strain
induc
express
recombin
protein
c
h
ad
isopropyl
mm
final
concentr
cultur
medium
reach
midlog
phase
od
recombin
denveiii
protein
purifi
use
nickelnitrilotriacet
acid
ninta
metalaffin
chromatographi
matric
qiagen
taigen
bioscienc
taipei
taiwan
denatur
condit
accord
manufactur
instruct
modif
briefli
inclus
bodi
contain
denveiii
obtain
sonic
lysi
buffer
mm
trishcl
mm
nacl
mm
edta
denatur
urea
cell
lysat
ninta
resin
incub
bind
buffer
urea
mm
nah
po
mm
trishcl
ph
room
temperatur
h
load
column
wash
wash
buffer
urea
mm
nah
po
mm
trishcl
ph
contain
triton
sigmaaldrich
remov
endotoxin
recombin
protein
elut
elut
buffer
urea
mm
nah
po
mm
trishcl
ph
refold
use
linear
urea
gradient
dialysi
buffer
mm
reduc
glutathion
mm
oxid
glutathion
mm
glycin
mm
edta
mm
trishcl
mm
nacl
mm
phenylmethylsulfonyl
fluorid
c
h
glutathion
transferas
gst
recombin
protein
use
control
protein
express
plasmid
transform
e
coli
strain
induc
express
protein
purifi
accord
protocol
previou
studi
endotoxin
contamin
verifi
limulu
amoebocyt
lysat
assay
lonza
accord
manufactur
instruct
describ
previous
antibodi
gener
purif
antibodi
denveiii
gener
purifi
follow
procedur
detail
previou
studi
modif
protein
g
sepharos
fast
flow
ge
healthcar
use
purifi
immunoglobulin
g
igg
serum
denveiii
immun
rabbit
accord
manufactori
instruct
elut
igg
dialyz
use
normal
salin
nacl
concentr
use
polyethylen
glycol
igg
preimmun
rabbit
serum
purifi
use
protocol
vivo
assay
perform
describ
previou
studi
modif
test
whether
denveiii
abil
suppress
megakaryopoiesi
vivo
denv
pfumous
pfuml
rang
approxim
equival
averag
viral
load
dengu
patient
pfuml
use
mice
male
week
bodi
weight
g
approxim
ml
blood
circul
treat
denv
pfumous
retroorbit
inject
twice
everi
h
treat
recombin
gst
denveiii
protein
mgkg
equal
mgml
circul
function
equival
pfu
denv
base
competit
analysi
describ
previous
fig
retroorbit
inject
everi
h
cycl
peripher
blood
collect
h
mk
isol
bone
marrow
analyz
describ
previous
h
first
denv
gst
denveiii
inject
mice
treat
salin
volum
time
cours
use
control
mous
bone
marrow
cell
isol
vitro
mk
differenti
perform
describ
previous
except
ngml
recombin
mous
thrombopoietin
rmtpo
peprotech
ad
differenti
medium
day
day
mous
bone
marrow
cell
treat
recombin
denveiii
mgml
function
equival
pfu
approxim
dose
trigger
megakaryopoiesi
suppress
vivo
block
approxim
infect
replic
denv
cell
fig
gst
protein
mgml
cell
surfac
marker
dna
content
analyz
day
describ
previous
bind
assay
denveiii
protein
mk
mk
isol
mous
bone
marrow
describ
previous
total
mk
incub
mg
purifi
recombin
denveiii
protein
c
h
ml
mk
buffer
bovin
serum
albumin
bsa
ca
mg
free
phosphat
buffer
salin
pb
contain
bsa
mm
prostaglandin
mm
dglucos
mm
tridodium
citrat
ph
wash
pb
cell
stain
antibodi
conjug
allophycocyanin
antidenveiii
antibodi
iggpurifi
preimmun
rabbit
serum
c
min
ml
mk
buffer
bsa
cell
wash
pb
incub
goat
antirabbit
igg
hcl
f
ab
fragment
conjug
fluorescein
isothiocyan
c
min
ml
mk
buffer
bsa
wash
pb
cell
dissolv
ml
pb
analyz
use
flow
cytometri
describ
previous
experiment
protocol
perform
accord
manufactur
instruct
megacultc
stemcel
technolog
vancouv
canada
procedur
describ
previou
public
briefli
mononuclear
cell
mnc
deriv
human
umbil
cord
blood
seed
doublechamb
slide
contain
cytokin
mk
differenti
mnc
treat
denveiii
mgml
gst
protein
mgml
incub
c
mk
coloni
identifi
antigpiibiiia
stain
count
counterstain
evan
blue
purif
human
cord
blood
c
cell
vitro
mk
differenti
perform
accord
previou
studi
modif
obtain
larg
number
c
cell
perform
mk
differenti
methylcellulos
gl
ad
slow
cell
movement
increas
cell
number
c
cell
treat
denveiii
mgml
gst
protein
mgml
day
incub
mk
differenti
medium
flow
cytometri
use
monitor
mk
differenti
apoptosi
day
describ
previous
autophag
cell
stain
use
cytoid
autophagi
detect
kit
enzo
life
scienc
ny
usa
day
analyz
use
flow
cytomet
facscalibur
bectondickinson
usa
mean
standard
deviat
sd
statist
quantifi
data
calcul
use
microsoft
offic
excel
comparison
group
made
use
student
test
p
valu
less
consid
signific
treatment
denv
pfumous
rang
approxim
equival
averag
viral
load
dengu
patient
analysi
reveal
denv
could
reduc
platelet
number
peripher
blood
mice
fig
b
previous
report
express
specif
surfac
marker
polyploid
use
identifi
mk
flow
cytometri
propidium
iodid
pi
stain
reveal
percentag
differenti
mk
larg
c
cell
region
polyploid
cell
dna
content
popul
region
significantli
suppress
denvtreat
mice
compar
salinetr
mice
fig
e
suggest
denv
suppress
megakaryopoiesi
mice
investig
whether
denveiii
suffici
suppress
megakaryopoiesi
mice
experiment
mice
treat
denveiii
mgkg
everi
h
cycl
fig
data
reveal
compar
salin
gsttreat
group
denveiiitr
mice
display
significantli
lower
count
cell
lower
percentag
polyploid
cell
region
fig
e
similar
respons
observ
denvtreat
mice
fig
e
result
suggest
denveiiimedi
suppress
megakaryopoiesi
play
crucial
role
denvinduc
neg
impact
mk
mice
investig
whether
denveiii
exert
suppress
effect
murin
mk
perform
vitro
megakaryocyt
differenti
use
erythrocytedeplet
mous
bone
marrow
cell
accord
describ
previous
method
treatment
denveiii
mg
ml
reduc
percentag
c
cell
popul
fig
c
region
dna
content
analysi
use
pi
stain
reveal
compar
gst
denveiii
reduc
percentag
polyploid
cell
increas
percentag
cell
significantli
fig
suggest
denveiii
suppress
megakaryopoiesi
primari
cultur
mous
haematopoiet
progenitor
cell
present
bone
marrow
investig
whether
denveiii
directli
bind
mk
murin
mk
purifi
bone
marrow
incub
denveiii
c
h
stain
antibodi
identifi
mk
stain
antidenveiii
antibodi
western
blot
analysi
reveal
antidenveiii
antibodi
specif
bound
denveiii
fig
flow
cytometri
analysi
data
reveal
percentag
denveiii
doubl
posit
cell
significantli
increas
compar
control
without
ad
denveiii
antidenveiii
antibodi
fig
f
indic
denveiii
could
bind
directli
surfac
mk
compar
murin
bone
marrow
human
umbil
cord
blood
rel
access
resourc
haematopoiet
progenitor
cell
cfumk
assay
perform
investig
whether
denveiii
abil
suppress
megakaryopoiesi
human
haematopoiet
progenitor
cell
data
reveal
compar
gsttreat
control
group
denveiiitr
group
show
signific
reduct
number
mk
coloni
fig
result
suggest
denveiii
suppress
megakaryopoiesi
primari
human
haematopoiet
progenitor
cell
next
investig
mechan
denveiii
treatment
lead
megakaryopoiesi
suppress
megakaryocyt
differenti
perform
use
human
umbil
cord
bloodderiv
c
cell
experi
fig
consist
previou
report
cell
size
fsc
cellular
granular
ssc
increas
induct
differenti
fig
day
vs
day
compar
vehicl
gst
treatment
denveiii
decreas
cell
number
region
increas
cell
number
region
fig
c
f
flow
cytometri
pi
stain
reveal
percentag
c
prematur
mk
c
c
matur
mk
cell
region
increas
significantli
denveiiitr
group
compar
vehicl
gsttreat
group
fig
e
g
result
suggest
denveiii
suppress
megakaryopoiesi
partli
initi
cell
death
prematur
matur
mk
recent
studi
reveal
autophagi
play
essenti
role
megakaryocyt
differenti
loss
autophagi
lead
failur
megakaryopoiesi
data
reveal
percentag
autophag
cell
decreas
region
increas
region
denveiii
denveiii
kill
differenti
mk
deriv
mous
bone
marrow
murin
bone
marrow
cell
erythrocytedeplet
fraction
isol
trigger
differenti
mk
presenc
mous
thrombopoietin
gst
protein
use
control
denveiii
gst
protein
ad
day
day
data
analyz
day
flow
cytometri
cell
stain
antibodi
c
cell
gate
analyz
dna
content
pi
stain
b
percentag
cell
among
analyz
cell
c
percentag
polyploid
cell
dna
content
hypoploid
cell
region
shown
murin
mk
isol
bone
marrow
incub
denveiii
protein
h
stain
antibodi
denveiii
igg
isol
preimmun
rabbit
serum
serv
control
ig
cig
cell
divid
group
c
antieiii
eiii
c
c
cig
eiii
c
c
antieiii
percentag
c
denveiii
c
doubl
posit
cell
among
total
cell
total
c
cell
analyz
e
quantifi
f
data
report
mean
sd
repres
c
f
independ
experi
p
p
compar
gsttreat
group
c
treat
group
compar
vehicletr
gsttreat
group
fig
addit
intens
cytoid
region
lower
region
denveiii
treat
group
fig
day
vs
day
result
indic
denveiii
trigger
impair
autophagi
furthermor
verifi
whether
cell
death
c
prematur
mk
c
c
matur
mk
autophagyimpair
cell
associ
apoptosi
annexin
v
activ
stain
perform
flow
cytometri
result
reveal
compar
vehicl
gst
treatment
denveiii
produc
significantli
annexin
v
c
activ
c
cell
region
fig
c
taken
togeth
data
indic
denveiii
suppress
megakaryopoiesi
human
cord
blood
c
cell
cultur
autophagi
impair
apoptosi
thrombocytopenia
import
manifest
denv
infect
associ
higher
mortal
howev
mechan
remain
unclear
bone
marrow
suppress
one
possibl
mechan
contribut
thrombocytopenia
studi
report
denv
directli
infect
mk
bone
marrow
human
monkey
interfer
megakaryopoiesi
howev
denv
elicit
thrombocytopenia
interfer
megakaryopoiesi
whether
viral
replic
requir
suppress
remain
elus
data
reveal
denveiii
suppress
megakaryopoiesi
independ
viral
infect
denveiiisuppress
megakaryopoiesi
associ
autophagi
impair
apoptosi
differenti
mk
fig
fig
find
suggest
denvinduc
thrombocytopenia
partli
mediat
suppress
effect
denveiii
megakaryopoiesi
theoret
presenc
addit
mechan
infect
replic
denv
mk
andor
nearbi
support
bone
marrow
stroma
cell
interf
mk
differenti
cell
surviv
remain
possibl
howev
unlik
human
mice
nativ
host
denv
therefor
denv
normal
replic
wild
type
mice
unless
mice
defici
interferon
ifn
ab
g
receptor
type
ifn
receptor
demonstr
denv
ca
nt
infect
replic
mous
mk
fig
data
suggest
denveiii
directli
bind
mk
fig
f
denveiii
alon
suffici
elicit
mk
suppress
decreas
platelet
number
similarli
vivo
effect
denv
fig
fig
hr
result
consist
vitro
data
obtain
mous
fig
human
cell
fig
reductionist
approach
use
mous
cellsmous
model
support
simpl
way
focu
effect
denveiii
megakaryopoiesi
irrespect
viral
replic
howev
approach
ca
nt
total
mimic
real
denv
infect
especi
vivo
model
denv
replic
mice
denv
nonetheless
induc
elicit
proinflammatori
cytokin
tnfa
well
known
elicit
thrombocytopen
respons
probabl
reason
denv
inject
higher
potenc
denveiii
elicit
thrombocytopen
respons
vs
hr
previou
studi
demonstr
impair
autophagi
led
apoptot
death
variou
cell
type
includ
mk
defici
result
mitochondri
damag
follow
apoptosi
mous
erythrocyt
matur
lymphocyt
similar
data
previou
public
data
show
denveiiiimpair
autophagi
associ
apoptosi
differenti
mk
fig
investig
warrant
elucid
detail
mechan
denveiii
induc
impair
autophagi
apoptosi
current
live
attenu
dengu
vaccin
assess
clinic
trial
denveiii
protein
subdomain
respons
denv
bind
target
cell
therefor
denveiii
feasibl
vaccin
candid
elicit
protect
antibodi
denveiiispecif
epitoperecogn
antibodi
amelior
clinic
symptom
infect
serotyp
denv
demonstr
human
mous
model
serotyp
denv
induc
thrombocytopenia
sequenc
denveiii
share
high
homolog
estim
similar
therefor
use
denveiii
subunit
vaccin
produc
neutral
antibodi
treatment
smallmolecul
denveiii
antagonist
theoret
block
denv
infect
also
amelior
denveiiiinduc
megakaryopoiesi
suppress
could
feasibl
approach
manag
sever
dengu
conclus
studi
provid
new
prospect
denveiii
virul
factor
suppress
megakaryopoiesi
denveiii
induc
cell
death
differenti
mk
autophagi
impair
apoptosi
denveiiiinduc
megakaryopoiesi
suppress
one
caus
thrombocytopenia
observ
denv
infect
therefor
denveiii
could
consid
drug
target
treat
mk
defect
thrombocytopenia
sever
dengu
potenti
conflict
interest
disclos
